FDA approves first treatment for Ebola, a Regeneron antibody cocktail
Approval may bolster hopes for Regeneron’s COVID-19 therapy, which uses same strategy.
Full Article
FDA approves first treatment for Ebola, a Regeneron antibody cocktail
Ars Technica
0 shares
3 views
You might like
Related news coverage
FDA Approves Antiviral Remdesivir As COVID-19 Treatment
Eurasia Review
The US Food and Drug Administration (FDA) has approved Gilead Sciences’ expensive antiviral drug remdesivir to treat Covid-19,..
Advertisement
More coverage
Can You Get The 'Antibody Cocktail' The President Got For COVID?
Newsy
Watch VideoMonoclonal antibodies or “antibody cocktails” are getting a lot of attention as the next promising treatment in the..
